1 PANEL KEGAWAT DARURATAN SISTEM PERNAPASAN (SERANGAN ASMA AKUT, PNEUMONIA DAN COPD) dan EDEMA PARU
ASTHMA 2
2 Agonist Bronchodilator Response Anticholinergic Asthma Response Panel A COPD Response Panel B 3
Terapi Asma Masa Depan Asma Tujuan penatalaksanaan asma : TOTAL KONTROL Intermiten Persisten Tidak terkontrol Terkontrol LABACS Maintain Tidak terkontrol Terkontrol Tingkatkan dosis Boushey H. Is Asthma Control Achieveable?, European Respiratory Journal, Dec 2004
Management of Asthma Exacerbations(Emergency) Inhaled beta 2 -agonist to provide prompt relief of airflow obstruction Systemic corticosteroids to suppress and reverse airway inflammation For moderate-to-severe exacerbations, or For patients who fail to respond promptly and completely to an inhaled beta 2 -agonist 5
Risk Factors for Death From Asthma Past history of sudden severe exacerbations Prior intubation or admission to ICU for asthma Two or more hospitalizations for asthma in the past year Three or more ED visits for asthma in the past year 6
Risk Factors for Death From Asthma (continued) Hospitalization or an ED visit for asthma in the past month Use of >2 canisters per month of inhaled shortacting beta 2 -agonist Current use of systemic corticosteroids or recent withdrawal from systemic corticosteroids
PNEUMONIA DEFINITION Inflammation and consolidation of lung tissue due to an infectious agent 9
COMMUNITY ACQUIRED (CAP) Outpatiet Typical Atypical Inpatient HOSPITAL ACQUIRED (HAP) ICU 10
Diagnosis of Pneumonia Clinical data points Cough Pleuritic chest pain Purulent sputum, Fever Leukocytosis Abnormal CXR Abnormal ABG Sputum cultures identify the pathogen
Signs of CAP Patients typically appear short of breath at rest Vital signs fever, increased heart rate and increased respiratory rate Chest exam crackles over the affected area Signs of consolidation: vocal and tactile fremitus, dullness to percussion, bronchial breath sounds, whispering egophony
Investigations to establish that a patient has CAP CXR Characteristically abnormal in CAP (some early disease may be an exception) White blood cell count - WBC with left shift (if bacterial) Sputum Gram stain
Treatment of CAP 14
Diagnosa HAP/Hospital Acquired Pneumonia)(Emergency) ATS (American thoracic Society, 1996). Bila gejala pneumonia, terjadi 48-72 jam penderita masuk rumah sakit, disebut HAP (dan diperkuat)dengan: Infiltrat baru atau perubahan infiltrat selagi terjadi onset baru Hipo/hipertermi Produksi sputum Lekositosis/lekopenia (Staufler, 1996) 15
MANAGEMENT Antibiotic therapy is the cornerstone of treatment for both CAP and HAP. Initial therapy should be instituted rapidly. Patients should initially be treated empirically, based on the severity of disease and the likely pathogens. 16
COPD 17
COPD - SIGNS HYPERINFLATION DECREASED EXPANSION CHEST PROLONGED EXPIRATION/±WHEEZE SIGNS PULMONARY HYPERTENSION AND/OR RVH (± CARDIAC FAILURE) CYANOSIS HYPERCAPNIA - ASTERIXUS, (PRE)- COMA 18
MANAGING EXACERBATIONS(Emergency) ANTIBIOTICS CONTROLLED OXYGEN BRONCHODILATOR - BETA AGONIST ANTICHOLINERGIC, ±THEOPHYLLINE STEROIDS INTUBATION/VENTILATION TREAT HEART FAILURE IF PRESENT (RESPIRATORY STIMULANTS?) 19
1 INHALED ANTICHOLINERGICS, ANTIBIOTICS IPRATROPIUM BROMIDE OXITROPIUM BROMIDE TIOTROPIUM BROMIDE 3 BETA 2 AGONIST BRONCHODILATORS FOR COPD 2 COMBINATION INHALER SHORT ACTING INHALED BETA 2 AGONIST 4 THEOPHYLLINE IPRATOPRIUM BROMIDE & SHORT ACTING INHALED BETA 2 AGONIST
Manage Exacerbations Key Points Inhaled bronchodilators (beta 2 -agonists and/or anticholinergics), theophylline, and systemic, preferably oral, glucocortico-steroids are effective for the treatment of COPD exacerbations (Evidence A).
Manage Exacerbations Key Points Patients experiencing COPD exacerbations with clinical signs of airway infection (e.g., increased volume and change of color of sputum, and/or fever) may benefit from antibiotic treatment (Evidence B).
pulmonary edema
24
Cause of acute pulmonary edema? Cardiogenic pulmonary edema Hydrostatic or Hemodynamic edema Non-cardiogenic pulmonary edema Increased-permeability pulmonary edema, acute lung injury or acute respiratory distress syndrome Difficult to distinguish because of similar clinical manifestations 25
Pulmonary Edema Management 26 THE END
Thanks for your attention!! 27